SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001539497-24-000149
Filing Date
2024-01-30
Accepted
2024-01-30 16:00:18
Documents
17
Period of Report
2024-01-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K n3936_x3-8k.htm   iXBRL 8-K 37830
2 NOTICE OF SPECIAL MEETING OF STOCKHOLDERS TO BE RECONVENED ON FEBRUARY 20, 2024, n3936_x3exh99-1.htm EX-99.1 24511
6 GRAPHIC proxy-page_1.jpg GRAPHIC 412499
7 GRAPHIC proxy-page_2.jpg GRAPHIC 424991
  Complete submission text file 0001539497-24-000149.txt   1398605

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE blcm-20240130.xsd EX-101.SCH 3015
4 XBRL LABEL FILE blcm-20240130_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE blcm-20240130_pre.xml EX-101.PRE 22359
18 EXTRACTED XBRL INSTANCE DOCUMENT n3936_x3-8k_htm.xml XML 6056
Mailing Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098
Business Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36783 | Film No.: 24578077
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)